Abstract:The Vero cell is the continuous cell line used as a cell substrate for many viral vaccines manufacturing including Rabies vaccine. The Pitman and PV-11 strains of rabies virus are commonly used for production of rabies vaccines. In our study the PV - 11 strain is used as seed virus for the production of Vero cell derived inactivated Anti Rabies Vaccines (Lyophilized). The working cell bank and working virus seed lot were prepared and tested for its sterility and mycoplasma contamination. In this study the roller bottle method and micro carrier (cytodex-1) based bioreactor culturing method were standardized with MEM Eagles and RPMI 1640 medium. The outcome of the two methods were compared ,to find out the medium and culturing method which can give higher concentration of Vero cells to get higher viral titre in mass production. The quantities of Vero cells obtained from passage 144 to 148 were assessed using a haemocytometer cell count procedure. The quantity of the Vero cell obtained per roller bottle ranged from 222.82x106 cells to 236.67x106 cells in MEM Eagles medium and 227.80x106 cells to 230.66x106 cells in RPMI 1640 medium. The average quantity of Vero cells in roller bottles were 1.12 x 106 cells per ml of culture. In the bioreactor culturing method the Vero cells obtained in the concentration of 1.69 to 1.75 million cells / ml of culture by MEM Eagles medium and 1.67 to 1.70 million cells / ml by RPMI 1640 medium. In the bioreactor the average yield of vero cells ranged 1.70 x106 cells per ml of culture. It is estimated that about 35% increase in Vero cell quantity in bioreactor system than the roller bottle culturing method. 0.3 MOI (Multiplicity of Infection) of rabies virus was kept as constant for infection of confluent monolayered Vero cells in both roller bottle and bioreactor culture. Four viral harvests were collected at three day intervals and replenished with fresh culturing medium each time. The viral titres in each viral harvest were quantified using in-house standardized RT-PCR method; the roller bottle method yielded viral titre log 6.044 to 7.106 and the bioreactor culture yielded log 6.559 to 7.216 rabies viral particles. It is observed that the bioreactor culture yielded more viral titre than the roller bottle culture using both the medium.

Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density

Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach

Establishment of an Efficient and Flexible Genetic Manipulation Platform Based on a Fosmid Library for Rapid Generation of Recombinant Pseudorabies Virus

Standardization of microcarrier based bioreactor culture in parallel with roller bottle for rabies virus (PV-11) propagation in Vero cell using MEM eagle’s and RPMI 1640 medium

A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice

Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle

Optimization of Virus Yield as a Strategy to Increase the Efficiency of Rabies Vaccine by BHK-21 Cells in a Bioreactor

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system

High-titer manufacturing of SARS-CoV-2 spike-pseudotyped VSV in stirred-tank bioreactors

Process Optimization for the Rapid Production of Adenoviral Vectors for Clinical Trials in a Disposable Bioreactor System.

Development and immunogenicity evaluation of a quadruple-gene-deleted pseudorabies virus strain

DROSOPHILA S2 cell culture in a WAVE Bioreactor: potential for scaling up the production of the recombinant rabies virus glycoprotein

Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits

The Construction and Immunogenicity Analyses of Recombinant Pseudorabies Virus With NADC30-Like Porcine Reproductive and Respiratory Syndrome Virus-Like Particles Co-expression

Fed‐batch strategies for intensified rVSV vector production in high cell density cultures of suspension HEK293 cells

Isolation and Characterization of Two Pseudorabies Virus and Evaluation of Their Effects on Host Natural Immune Responses and Pathogenicity

Construction and immunogenicity of a gE/gI/TK-deleted PRV based on porcine pseudorabies virus variant

Construction of recombinant pseudorabies virus expressing PCV2 Cap, PCV3 Cap, and IL-4: investigation of their biological characteristics and immunogenicity

Process optimization for the rapid production of Enterovirus 71

A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection.

Immune Responses Induced by a Recombinant Lactiplantibacillus plantarum Surface-Displaying the gD Protein of Pseudorabies Virus